biotechs

Two big biotech runs over the last week and a half, ADO then VLA.
Interesting to compare/contrast with TIS.
ADO is where we are looking at being later in the year, first commercial deal signed, but no real indicator of revenue yet.
VLA however is years away, just completing Phase I studies, they are so far from turning a profit out of the result released today its not funny.

Its looks like biotechs are hot however, and a good write up or release at the moment could serve us well.
Interesting time ahead hopefully.